BackMoonLake Immunotherapeutics Overview

MoonLake Immunotherapeutics Total Assets

Latest total assets for MLTX: $540M.

Get informed when a big investor buys or sells

+ Follow
Total Assets
$540.72M
↑ 30.50% YoYΔ $126.38M vs prior year quarter

Peer trimmed avg / median

Loading

MoonLake Immunotherapeutics Total Assets History

Loading

MoonLake Immunotherapeutics vs. peers: Total Assets Comparison

Loading

MoonLake Immunotherapeutics Total Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MoonLake Immunotherapeutics (MLTX) FAQ

The latest total assets for MLTX is $540M as of September 2026. That compares with $410M in the prior-year period — up 30.5% year over year. Investors often review this figure alongside MoonLake Immunotherapeutics's historical trend and sector peers before judging valuation or financial health.

Over the past year, MLTX's total assets moved from $410M to $540M — a 30.5% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MoonLake Immunotherapeutics's operating scale or balance-sheet position.

A total assets figure of $540M for MLTX is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MLTX's total assets ($540M), review year-over-year change from $410M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.